Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 1540Leukemia 1389Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Leukemia, Lymphocytic, Chronic, B-Cell 1090Myelodysplastic Syndromes 722Lymphoma 658Lymphoma, Non-Hodgkin 627Hematologic Neoplasms 556Lymphoma, Follicular 487Leukemia, Myelogenous, Chronic, BCR-ABL Positive 470Lymphoma, Mantle-Cell 459Lymphoma, Large B-Cell, Diffuse 444Burkitt Lymphoma 432Hodgkin Disease 431Lymphoma, B-Cell, Marginal Zone 424Multiple Myeloma 415Lymphoma, Large-Cell, Immunoblastic 335Leukemia, Myelomonocytic, Chronic 314Congenital Abnormalities 287Recurrence 279Leukemia, Myeloid, Chronic-Phase 272Myeloproliferative Disorders 260Neoplasms 256Blast Crisis 250Waldenstrom Macroglobulinemia 232Leukemia, Myeloid, Accelerated Phase 217Lymphoma, T-Cell, Cutaneous 213Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 208Mycosis Fungoides 183Lymphoma, Large-Cell, Anaplastic 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Treatment Adherence and Compliance × Other hematologic neoplasm × Clear all
NCT05260203 2024-11-06

MargheRITA

Advice Pharma Group srl

Phase NA Completed
124 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡